The Long-term Release of Antibiotics From Monolithic Nonporous Polymer Implants for Use as Tympanostomy Tubes

A technology is elaborated for the fabrication of a novel tympanostomy tube (TT) from solidified polymer melts (Elvax and Polyurethane) and antibiotics (Ciprofloxacin and Usnic acid) for insertion into tympanic membrane (ear drum) according to the established surgical procedure. The long-term in vitro release kinetics of the antibiotics into liquid water has been assessed using standard methods. The measured kinetic curves revealed two stages of antibiotic release into the finite space. During the first stage (fast), the fast release rate is almost invariant and is determined by the diffusion through the steady diffusion layer formed due to solution agitation. In this first stage, the influence of the initial internal transport is weak because it takes place at negligibly small distance from interface and accordingly, at negligibly concentration drop. After the antibiotic concentration decreases within the much broader layer of matrix near interface, the internal transport becomes important. This manifests itself as the second stage in measured kinetics of release curves which is characterized by a gradual decrease in rate. The minimum inhibition concentrations of three antibiotics/antimicrobial compounds for four bacterial species were measured. The first stage of fast release from the polymer implant lasts 6 days at a polymer loading by Ciprofloxacin (0.03 g/cm(3)) and this was sufficient for preventing biofilm formation on the surface of the implant material. The measured kinetic curves of drug release showed more rapid decrease in the release rate compared to the Higuchi approximation. Comparison with existing theories, which account for the finite rate of drug dissolution, showed that this may explain the observed deviation from the diffusion-controlled Higuchi model. Large dimensions of drug particles and their aggregation retard the dissolution stage and consequently the release rate. Melt blending was found to cause the drug particle aggregation within polymer matrixes which was confirmed by microscopic reexamination of the polymer implant materials.     

聚L-谷氨酸担载胰岛素口服微球的制备与评价

以聚L-谷氨酸为载体材料, 采用无水乳液法制备了口服胰岛素微球, 微球直径在5~20 μm, 载药质量分数为5%~9%. 载药微球具有良好的pH敏感释放行为, 在胃模拟液中2 h释放量约为5%, 在肠道模拟液中2 h释放90%以上. 考察聚合物分子量、溶液浓度、理论投药量及混合材料对微球释放行为的影响.     

Influence of the structure and morphology of ultrathin poly(3-hydroxybutyrate) fibers on the diffusion kinetics and transport of drugs

Ultrathin fibers of a biodegradable polymer poly(3-hydroxybutyrate) with an encapsulated drug (dipyridamole, 0–5% of poly(3-hydroxybutyrate) mass) are obtained by electrospinning. Introduction of the drug substantially affects the geometric shape and crystallinity of individual filaments as well as the total porosity of the fibrillar film on their basis. As follows from the SEM data, in the absence of the drug or at its low concentration (<3%), poly(3-hydroxybutyrate) fibers appear as ellipse-like fragments alternating with cylindrical ones. At a higher content of the drug (3–5%), the abnormal ellipse-like structures are practically absent and the fiber acquires the cylindrical shape. A set of morphological and crystallinity characteristics of the fibers determines the absorption of water and the rate of the diffusion transport of the drug as well as the corresponding profiles of its controlled release. A simplified model of drug desorption from the fibrillar film is advanced which considers two sequential stages of the process: (i) diffusion of the drug in the polymer fiber with coefficient D _f ~ 10^–12 cm²/s and dimeter φ_f ~ 2–4 μm and (ii) transport of the drug in the interfibrillar porous space filled by solvent with diffusion coefficient D _w = 5.5 × 10^–6 cm²/s. Using the characteristics of porosity, crystallinity, and geometry of the fibers and diffusion effective coefficients D _eff calculated from the profile of drug release, it is shown that the limiting stage of the transport of the drug is its diffusion in the volume of the cylindrical fiber. The model makes it possible to turn from the experimental values of D _eff to partial diffusion coefficients D _f and to calculate the kinetic profile of drug release with allowance made for the above-listed factors.     

Hierarchical Micro/Nanostructures of Natural Polymer for Release Process

In this paper the modeling of drug release process from hierarchical dispersed systems such as nano and microparticles prepared by thermal cross-linking of multiple emulsions is described. The presented model considers the diffusion of a drug through spherical eroding natural polymer matrix and diffusion-convection of the drug in the surrounding medium. Simulated release profiles were compared with experimental data of the drug release from microspheres of various structures. The differences in microspheres structure resulted from changes in mixing intensity of the external surrounding. The simulations of release profiles confirmed the importance of the internal structure of microspheres as well as an intensity of external mixing in the modeling of the controlled release process. The presented model allowed the mass of drug released to be determined with satisfactory agreement with experimental data after optimization of parameters describing internal microspheres structure. The proposed model describing release process of a drug from microspheres can be applied for simulation of release profiles with phasic behavior (primary/lag and continuous release). The model simulations were extended to drug release from nanoparticles with satisfactory results.     

Influence of drug on the structure and segmental mobility of poly(3-hydroxybutyrate) ultrafine fibers

Ultrafine fibers of biodegradable natural polyester such as poly(3-hydroxybutyrate) containing dipyridamole at various concentrations as a drug are prepared by the electrospinning method. It is shown by scanning electron microscopy that the absence of dipyridamole or its low concentrations (from 0 to 1%) provide the complex morphology of fibers composed of cylindrical regions 1–3 μm in diameter and thickened spindle-like ones 5–7 μm in average diameter. An increase in the concentration of dipyridamole in fibers leads to disappearance of the latter regions, with the morphology being cylindrical. The features of the crystalline and amorphous structures of poly(3-hydroxybutyrate) and its mixtures with dipyridamole are examined via DSC and EPR probe techniques. It is shown that the addition of dipyridamole to the poly(3- hydroxybutyrate) polymer matrix results in a sharp increase in the crystallinity and a slowdown of the molecular mobility in amorphous regions of ultrafine fibers. The heat treatment (annealing) of fibers leads to a sharp increase in the polymer crystallinity and a reduction of the segmental mobility in intercrystalline regions of the initial poly(3-hydroxybutyrate) fibers and those containing 1% of dipyridamole. All results including the influence of the drug concentration on the shape of fibers and their dynamic characteristics agree well with the thermal and physical parameters and should be used in the design of therapeutic systems for targeted and sustained delivery of bioactive compounds.     

Controlled-release and antibacterial studies of doxycycline-loaded poly(ε-caprolactone) microspheres

The objective of the present study is to achieve doxycycline’s maximum therapeutic efficacy. Doxycycline-loaded poly(ε-caprolactone) microspheres were prepared by water-in-oil-in-water (w/o/w) double emulsion solvent evaporation technique with different formulation variables such as concentrations of drug and polymer. The effects of these variables on surface morphology, particle size distribution, encapsulation efficiency, and in vitro release behavior were examined. To observe the nature of microspheres, X-ray diffraction studies were carried out. The release data obtained were determined using various kinetic models and Korsmeyer–Peppas model showed an acceptable regression value for all compositions. Antibacterial efficiency of doxycycline-loaded poly(ε-caprolactone) microspheres were assessed by determining Minimum Inhibition Concentration (MIC) by standard tube dilution method against four standard pathogenic strains. The in vitro drug release studies were carried out in phosphate buffer solution (pH 7.2). The results showed marked retardation of doxycycline release and higher percentage of polymer gave longer drug release profile. This may definitely provide a useful controlled-release drug therapy and also prove to be effective over a long period of time (76 h).     

Encapsulation and sustained release of a model drug, indomethacin, using CO(2)-based microencapsulation

A carbon dioxide (CO(2))-based microencapsulation technique was used to impregnate indomethacin, a model drug, into biodegradable polymer nanoparticles. Compressed CO(2) was emulsified into aqueous suspensions of biodegradable particles. The CO(2) plasticizes the biodegradable polymers, increasing the drug diffusion rate in the particles so that drug loading is enhanced. Four types of biodegradable polymers were investigated, including poly(d,l-lactic acid) (PLA), poly(d,l-lactic acid-co-glycolic acid) (PLGA) with two different molar ratios of LA to GA, and a poly(d,l-lactic acid-b-ethylene glycol) (PLA-PEG) block copolymer. Biodegradable nanoparticles were prepared from polymer solutions through nonsolvent-induced precipitation in the presence of surfactants. Indomethacin was incorporated into biodegradable nanoparticles with no change of the particle size and morphology. The effects of a variety of experimental variables on the drug loadings were investigated. It was found that the drug loading was the highest for PLA homopolymer and decreased in PLGA copolymers as the fraction of glycolic acid increased. Indomethacin was predicted to have higher solubility in PLA than in PLGA based on the calculated solubility parameters. The drug loading in PLA increased markedly as the temperature for impregnation was increased from 35 to 45 degrees C. Drug release from the particles is a diffusion-controlled process, and sustained release can be maintained over 10 h. A simple Fickian diffusion model was used to estimate the diffusion coefficients of indomethacin in the biodegradable polymers. The diffusion coefficients are consistent with previous studies, suggesting that the polymer properties are unchanged by supercritical fluid processing. Supercritical CO(2) is nontoxic, easily separated from the polymers, can extract residual organic solvent, and can sterilize biodegradable polymers. The CO(2)-based microencapsulation technique is promising for the production of drug delivery devices without the use of harmful solvents.     

Facile method for synthesis of hollow porous magnetic microspheres with controllable structure

Hollow porous magnetic microspheres with strong magnetization and controllable structure were prepared via a facile electrostatic self-assembly of the positively charged Fe(3)O(4) nanoparticles onto the surface of the negatively charged poly(N,N'-methylenebisacrylamide-co-methacrylic acid) (P(MBAAm-co-MAA)) microspheres with subsequent removal of the polymer core through calcination at high temperature. The shell thickness was facilely tuned through the ratio between Fe(3)O(4) and polymer, and the void space was conveniently changed through the size of polymer microspheres. The hollow magnetic microspheres possessed high saturation magnetization value (51.38 emu/g) and porous structure with high specific surface area (108.04 m(2)/g). Based on these properties, the drug loading and release behaviors were investigated, which indicated that the hollow magnetic microspheres exhibited a controlled release process.     

生物可降解5-氟尿嘧啶载药微球的制备及性能研究

5-氟尿嘧啶(5-Fu)为水溶性嘧啶类抗代谢药,是治疗实体肿瘤的首选药物．但5-Fu毒性很大,血浆中停留半衰期t1／2仅为10～20min．为了减少氟尿嘧啶的毒副作用并提高药物利用率,可以将其制成聚合物载药微球．聚酯类高分子是较为常用的生物降解型药物载体材料,其中聚乳酸(PLA)及其共聚物具有良好的生物相容性及生物可降解性,常被广泛应用于药物缓释材料,     

Structure and prolonged transport in a biodegradable poly(R-3-hydroxybutyrate)-drug system

In order to create new biodegradable systems for the targeted transport of drugs, poly(3-hydroxy-butyrate) films containing the antibiotic rifampicin in an amount of 5–15 wt % as a model drug are prepared. Film surfaces are studied via scanning electron microscopy, and various structural elements (globules and fibrils) are found. Polymer samples isolated from melt or solution feature different degrees of porosity. It is shown that the kinetic profiles of rifampicin release are of an abnormal character. An analysis of the profiles shows that the release of rifampicin is controlled by the superposition of two processes: its desorption via the diffusion mechanism (the nonlinear segment) and hydrolytic degradation of poly(3-hydroxybutyrate) (the extended linear segment), which becomes well defined after completion of the diffusion stage. The diffusionkinetic model of the process is developed.     

Control of prolonged drug release and compression properties of ibuprofen microspheres with acrylic polymer, eudragit RS, by changing their intraparticle porosity [corrected]

Prolonged-release spherical micro-matrices of ibuprofen with Eudragit RS were prepared using a novel emulsion-solvent diffusion method. Those particles were termed "microspheres" due to their characteristic sponge-like texture and unique dissolution and compression properties unlike conventional microcapsules or microspheres. The internal porosity of microspheres could be easily controlled by changing the concentration of the drug and the polymer in the emulsion droplet (ethanol). With lower concentration of ibuprofen in the ethanol, the resultant microspheres had a higher porosity, about 50%. The drug release rate from the microspheres was interpreted by the Higuchi model of spherical matrices, which depended only on their internal porosity of the microspheres when size distribution and drug content were the same. The tortuosities in the microspheres were found to be almost constant (3-4) irrespective of porosity, suggesting the same internal texture. Microsphere compressibility was much improved over the physical mixture of the drug and polymer owing to the plastic deformation of their sponge-like structure. The more porous microspheres produced stronger tablets [corrected].     

Enhanced gentamicin loading and release of PLGA and PLHMGA microspheres by varying the formulation parameters

The purpose of this study was to develop a suitable formulation for gentamicin sulfate (GS) that gives a sustained release of the drug. Therefore this drug was loaded into poly(D,L-lactide-co-glycolide) (PLGA) and poly(lactic-co-hydroxymethyl glycolic acid) (PLHMGA) microspheres. The effects of various formulation parameters (ethanol, surfactant, osmotic value of the external phase, polymer type and concentration) on particle characteristics (size, loading and release) were investigated. The GS loaded microspheres were prepared using a double emulsion evaporation technique. The results demonstrate that neither ethanol nor surfactants had beneficial effects on the drug loading efficiency (around 4-10%). However, an increase in buffer concentration (and thus osmotic pressure) of the external phase resulted in a substantial increase of GS-loading (from 10 to 28%). Further, an increase of concentration of PLGA in DCM from 10% to 15/20% caused a 4-time increase of the drug loading. The best formulation identified in this study had a loading efficiency of around 70% resulting in PLGA microspheres with a 6% (w/w) loading. The particles showed a burst release of the drug depending on their porosity, followed by a phase of 35 days where hardly any release occurred. The drug was then slowly released for around 25 days likely due to degradation of the microspheres. The drug loading efficiency of GS in PLHMGA was not significantly different from PLGA microspheres (64%). The release of GS from PLHMGA microspheres was faster than that of PLGA because the degradation rate of PLHMGA is more rapid than PLGA. This study shows that prolonged release of gentamicin can be obtained by loading this drug into microspheres made of biodegradable aliphatic polyesters.     

磁性热敏聚合物微球的制备及磁感应控制释放行为

采用种子乳液聚合法在Fe3O4纳米粒子表面聚合包覆N-异丙基丙烯酰胺(NIPAM)与α-甲基丙烯酸(MAA)的共聚物,制备了磁性热敏聚合物微球Fe3O4/P(NIPAM-co-MAA).利用广角X射线衍射仪(WAXD)、透射电子显微镜(TEM)、zeta粒度仪(DLS)、热重分析(TGA)、振动样品磁力计(VSM)及比表面积测试仪(BET)等对微球的结构与形貌进行了表征,通过紫外-可见光分光光度法(UV-Vis)研究了微球对水溶性模型药物罗丹明B(RhB)的负载和磁感应控制释放行为.结果表明,微球粒径为80～200 nm,比表面积约为30.04m2/g,平均孔径约为24.50 nm;微球中聚合物含量约为73 wt%,磁粒子含量约为20 wt%,饱和磁感应强度为16.49 emu/g,其体积相转变温度(VPTT)约为37.5℃.RhB在微球中的装载量可以达到16.38 mg/g;在外加交变磁场作用下,RhB在模拟肠液和胃液中的磁感应释放量分别达到10.47和13.02 mg/g.     

PREPARATION OF MONODISPERSE CROSSLINKED POLYMER MICROSPHERES HAVING CHLOROMETHYL GROUP BY DISTILLATION-PRECIPITATION POLYMERIZATION

Monodisperse crosslinked poly(chloromethylstyrene-co-divinylbenzene) (poly(CMSt-co-DVB)) microspheres were prepared by distillation-precipitation copolymerization of chloromethylstyrene (CMSt) and divinylbenzene (DVB) in neat acetonitrile. The polymer particles had clean surfaces due to the absence of any added stabilizer. The size of the particles ranges from 2.59 μm to 3.19 μm and with mono-dispersity around 1.002-1.014. The effects of monomer feed in copolymerization on the microsphere formation were described. The polymer microspheres were characterized by SEM and chlorinity elemental analysis.     

Size effect on competition of two diffusion mechanisms for drug molecules in amorphous polymers

Diffusion of drug molecules in polymer materials is of great importance in controlled drug release, and the investigation of the mechanism of drug release from the polymer matrix would help us to understand the release behavior of the controlled release system. In this work, molecular dynamics simulations were employed to investigate the diffusion mechanisms of penetrant molecules with different sizes in poly(lactic acid-co-ethylene glycol) (PLA-PEG). The size effect on the diffusion mechanism of penetrant molecules in polymer matrixes was discussed in detail. A competition mechanism in a two-step diffusion process-(1) motion within the cavities (free volumes), and (2) jumps between cavities or movement of the cavity itself originated from the wriggling of the polymer chains-was observed, and the contributions of these two factors to the diffusion coefficient were successfully separated. With the medium volume of penetrant molecules (e.g., benzene), a competition between these two steps was observed. Step (2) controlled the diffusion when penetrant molecules became bigger.     

Preparation, characterization, and pharmacodynamics of exenatide-loaded poly(DL-lactic-co-glycolic acid) microspheres

Exenatide (synthetic exendin-4), a 39-amino acid peptide, was encapsulated in poly(DL-lactic-co-glycolic acid) (PLGA) microspheres as a sustained release delivery system for the therapy of type 2 diabetes mellitus. The microspheres were prepared by a double-emulsion solvent evaporation method and the particle size, surface morphology, drug encapsulation efficiency, in vitro release profiles and in vivo hypoglycemic activity were evaluated. The results indicated that the morphology of the exenatide PLGA microspheres presented as a spherical shape with smooth surface, and the particle sizes distributed from 5.8 to 13.6 μm. The drug encapsulation efficiency tested by micro-bicinchoninic acid (BCA) assay was influenced by certain parameters such as inner and outer aqueous phase volume, PLGA concentration in oil phase, polyvinyl alcohol (PVA) concentrations in outer aqueous phase. Moreover, in vitro release behaviors were also affected by some parameters such as polymer type, PLGA molecular, internal aqueous phase volume, PLGA concentration. The pharmacodynamics in streptozotocin (STZ)-induced diabetic mice suggested that, exenatide microspheres have a significant hypoglycemic activity within one month, and its controlling of plasma glucose was similar to that of exenatide solution injected twice daily with identical exenatide amount. In conclusion, this microsphere could be a well sustained delivery system for exenatide to treat type 2 diabetes mellitus.     

Polymer Structure‐Guided Self‐Assisted Preparation of Poly(ester‐thioether)‐Based Hollow Porous Microspheres and Hierarchically Interconnected Microcages for Drug Release

Porous polymer microspheres (PPMs) have been widely applied in various biomedical fields. Herein, the self‐assisted preparation of poly(ester‐thioether)‐based porous microspheres and hierarchical microcages, whose pore sizes can be controlled by varying the polymer structures, is reported. Poly(ester‐thioether)s with alkyl side chains (carbon atom numbers were 2, 4, and 8) can generate hollow porous microspheres; the longer alkyl chain length, the larger pore size of microspheres. The allyl‐modified poly(ester‐thioether) (PHBDT‐g‐C₃) can form highly open, hierarchically interconnected microcages. A formation mechanism of these PPMs is proposed; the hydrophobic side chains‐mediated stabilization of oil droplets dictate the droplet aggregation and following solvent evaporation, which is the key to the formation of PPMs. The hierarchically interconnected microcages of PHBDT‐g‐C₃ are due to the partially crosslinking of polymers. Pore sizes of PPMs can be further tuned by a simple mixing strategy of poly(ester‐thioether)s with different pore‐forming abilities. The potential application of these PPMs as H₂O₂‐responsive vehicles for delivery of hydrophobic (Nile Red) and hydrophilic (doxorubicin hydrochloride) cargos is also investigated. The microspheres with larger pore sizes show faster in vitro drug release. The poly(ester‐thioether)‐based polymer microspheres can open a new avenue for the design of PPMs and provide a H₂O₂‐responsive drug delivery platform.     

Polycarbonate microspheres containing mitomycin C and magnetic powders as potential hepatic carcinoma therapeutics

The polycarbonate copolymer poly(trimethylene carbonate-co-5,5-dimethyl trimethylene carbonate) (P(TMC-co-DTC)) was synthesized by the polymerization of trimethylene carbonate (TMC) and 5,5-dimethyl trimethylene carbonate (DTC) using tin (II) 2-ethylhexanoate [Sn(Oct)(2)] as a catalyst. In vitro degradation tests indicated this polycarbonate copolymer degraded slowly in phosphate buffer saline solution (PBS, 0.1 mol/L, at 37°C). Magnetic polymer microspheres (MMC-PC-M) generated from the P(TMC-co-DTC) copolymer and containing Fe(3)O(4) magnetic ultrafine powders and an anticancer drug, mitomycin C (MMC) were prepared by a solvent evaporation technique. These anticancer magnetic polycarbonate microspheres showed strong magnetic responsiveness and high MMC loading capacity. In vitro drug release studies indicated that these microspheres sustained steady release rates of MMC in PBS. In vitro cytotoxicity assays demonstrated the microspheres were strongly inhibitory to human hepatic carcinoma (Bel-7204) cells. In vivo site-specific therapy in nude mice with human hepatic carcinoma indicated that the microspheres possessed markedly high antitumor activity against human hepatic carcinoma (Bel-7204).     

The influence of transverse differential swelling stresses on the kinetics of sorption of penetrants by polymer membranes

The influence of transverse differential swelling stresses on the kinetics of sorption of a penetrant in a polymer membrane exhibiting linear viscoelasticity is described by a model developed from the much simpler one of Crank. Sorption and transverse swelling kinetic curves are computed numerically. The character of absorption and desorption curves is examined systematically mainly as a function of (i) the magnitude of the stresses set up and of the stress-dependence of the diffusion coefficient, (ii) the relative rates of stress relaxation and of diffusion, and (iii) the degree of plasticization or “softening” of the polymer by the penetrant. It is shown that important general features of experimental sorption kinetic curves can be reproduced satisfactorily under well defined conditions. Attention is also given to transverse swelling kinetic curves. Their correlation with the corresponding sorption curves is examined briefly but systematically and discussed with reference to experimental data.     

Performance of biodegradable microcapsules of poly(butylene succinate), poly(butylene succinate-co-adipate) and poly(butylene terephthalate-co-adipate) as drug encapsulation systems

Poly(butylene succinate) (PBSu), poly(butylene succinate-co-adipate) (PBSA) and poly(butylene terephthalate-co-adipate) (PBTA) microcapsules were prepared by the double emulsion/solvent evaporation method. The effect of polymer and poly(vinyl alcohol) (PVA) concentration on the microcapsule morphologies, drug encapsulation efficiency (EE) and drug loading (DL) of bovine serum albumin (BSA) and all-trans retinoic acid (atRA) were all investigated. As a result, the sizes of PBSu, PBSA and PBTA microcapsules were increased significantly by varying polymer concentrations from 6 to 9%. atRA was encapsulated into the microcapsules with an high level of approximately 95% EE. The highest EE and DL of BSA were observed at 1% polymer concentration in values of 60 and 37%, respectively. 4% PVA was found as the optimum concentration and resulted in 75% EE and 14% DL of BSA. The BSA release from the capsules of PBSA was the longest, with 10% release in the first day and a steady release of 17% until the end of day 28. The release of atRA from PBSu microcapsules showed a zero-order profile for 2 weeks, keeping a steady release rate during 4 weeks with a 9% cumulative release. Similarly, the PBSA microcapsules showed a prolonged and a steady release of atRA during 6 weeks with 12% release. In the case of PBTA microcapsules, after a burst release of 10% in the first day, showed a parabolic release profile of atRA during 42 days, releasing 36% of atRA.